Thrombosis
News
FDA, CDC urge pause of J&J COVID vaccine
Treatment for traditional blood clots, such as the drug heparin, should not be used for these clots.
News
Novel antiplatelet drug: Hope for efficacy without bleeding?
A new antiplatelet drug with a completely novel mechanism of action could hold the promise of delivering the holy grail – reducing cardiac events...
News
AstraZeneca COVID vaccine: Clotting disorder mechanism revealed?
The vaccine may be linked to a condition that clinically resembles heparin-induced thrombocytopenia and seems to occur mainly in younger women.
News
DOACs offered after heart valve surgery despite absence of data
Use of direct oral anticoagulants following heart valve surgery is occurring despite relative contraindications, but expert doubts its clinical...
News
Late-window stroke thrombolysis not linked to clot migration
This is the first randomized controlled study to assess the effect of thrombolysis on clot migration and accessibility in an extended time window...
News
Microthrombi, necrosis seen in COVID-19 hearts on autopsy
A new autopsy series shows microthrombi and focal necrosis in hearts of patients who died of COVID-19. The findings support use of anticoagulation...
Clinical
DAPT increases bleeding without decreasing mortality in patients with coronary disease and diabetes
In patients who have diabetes with known coronary disease but without prior MI or stroke, what is the effect of dual-antiplatelet therapy (DAPT)...
Clinical
Anticoagulation and antiplatelet therapy after GI bleed cut mortality, ischemic events
In patients who present with a gastrointestinal bleed (GIB) while on an anticoagulants (AC) or antiplatelets (AP), what are the risks and benefits...
News
Full-dose anticoagulation reduces need for life support in COVID-19
Clinical
DOACs show safety benefit in early stages of CKD
In terms of efficacy and bleeding risk, what is known about anticoagulation in patients with chronically impaired renal function?